209 related articles for article (PubMed ID: 29508386)
21. Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia.
Zhang Y; Zhou X; Li Y; Xu Y; Lu K; Li P; Wang X
Oncogene; 2018 Oct; 37(41):5520-5533. PubMed ID: 29895969
[TBL] [Abstract][Full Text] [Related]
22. Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.
Palacios F; Yan XJ; Ferrer G; Chen SS; Vergani S; Yang X; Gardner J; Barrientos JC; Rock P; Burack R; Kolitz JE; Allen SL; Kharas MG; Abdel-Wahab O; Rai KR; Chiorazzi N
Leukemia; 2021 Apr; 35(4):1037-1052. PubMed ID: 33504942
[TBL] [Abstract][Full Text] [Related]
23. Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia.
Arruga F; Gizdic B; Serra S; Vaisitti T; Ciardullo C; Coscia M; Laurenti L; D'Arena G; Jaksic O; Inghirami G; Rossi D; Gaidano G; Deaglio S
Leukemia; 2014 May; 28(5):1060-70. PubMed ID: 24170027
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of c-Myc-dependent heterogeneous nuclear ribonucleoprotein A1 promotes proliferation and inhibits apoptosis in NOTCH1-mutated chronic lymphocytic leukemia cells.
Zou Y; Tang H; Miao Y; Zhu H; Wang L; Fan L; Fu J; Xu W; Li J; Xia Y
Chin Med J (Engl); 2022 Apr; 135(8):920-929. PubMed ID: 35730371
[TBL] [Abstract][Full Text] [Related]
25. Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications.
Arruga F; Bracciamà V; Vitale N; Vaisitti T; Gizzi K; Yeomans A; Coscia M; D'Arena G; Gaidano G; Allan JN; Furman RR; Packham G; Forconi F; Deaglio S
Leukemia; 2020 Feb; 34(2):462-477. PubMed ID: 31467429
[TBL] [Abstract][Full Text] [Related]
26. Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation.
Onaindia A; Gómez S; Piris-Villaespesa M; Martínez-Laperche C; Cereceda L; Montes-Moreno S; Batlle A; de Villambrosia SG; Pollán M; Martín-Acosta P; González-Rincón J; Menarguez J; Alvés J; Rodriguez-Pinilla SM; García JF; Mollejo M; Fraga M; García-Marco JA; Piris MA; Sánchez-Beato M
Haematologica; 2015 May; 100(5):e200-3. PubMed ID: 25552700
[No Abstract] [Full Text] [Related]
27. NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients.
Willander K; Dutta RK; Ungerbäck J; Gunnarsson R; Juliusson G; Fredrikson M; Linderholm M; Söderkvist P
BMC Cancer; 2013 Jun; 13():274. PubMed ID: 23734977
[TBL] [Abstract][Full Text] [Related]
28. NOTCH1 mutation in chronic lymphocytic leukaemia is associated with an enhanced cell cycle G1/S transition and specific cyclin overexpression: Preclinical ground for targeted inhibition.
Carrillo-Tornel S; Chen-Liang TH; Zurdo M; Puiggros A; Gómez-Llonín A; García-Malo MD; Cuenca-Zamora EJ; Ortuño FJ; López AMH; Espinet B; Jerez A
Br J Haematol; 2023 May; 201(3):470-479. PubMed ID: 36573331
[TBL] [Abstract][Full Text] [Related]
29. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.
Del Giudice I; Rossi D; Chiaretti S; Marinelli M; Tavolaro S; Gabrielli S; Laurenti L; Marasca R; Rasi S; Fangazio M; Guarini A; Gaidano G; Foà R
Haematologica; 2012 Mar; 97(3):437-41. PubMed ID: 22207691
[TBL] [Abstract][Full Text] [Related]
30.
Close V; Close W; Kugler SJ; Reichenzeller M; Yosifov DY; Bloehdorn J; Pan L; Tausch E; Westhoff MA; Döhner H; Stilgenbauer S; Oswald F; Mertens D
Blood; 2019 Feb; 133(8):830-839. PubMed ID: 30510140
[No Abstract] [Full Text] [Related]
31. GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL.
De Falco F; Rompietti C; Sorcini D; Esposito A; Scialdone A; Baldoni S; Del Papa B; Adamo FM; Silva Barcelos EC; Dorillo E; Stella A; Di Ianni M; Screpanti I; Sportoletti P; Rosati E
Cell Death Dis; 2022 Sep; 13(9):755. PubMed ID: 36050315
[TBL] [Abstract][Full Text] [Related]
32. Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia.
Jelloul FZ; Yang R; Garces S; Kanagal-Shamanna R; Ok CY; Loghavi S; Routbort MJ; Zuo Z; Yin CC; Floyd K; Bassett RL; Wierda W; Jain N; Thompson P; Luthra R; Medeiros LJ; Patel KP
Leuk Res; 2022 May; 116():106827. PubMed ID: 35430388
[TBL] [Abstract][Full Text] [Related]
33. Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: any role for Notch, Wnt and Hh signaling pathways?
Seke Etet PF; Vecchio L; Nwabo Kamdje AH
Cell Signal; 2012 Jul; 24(7):1433-43. PubMed ID: 22446006
[TBL] [Abstract][Full Text] [Related]
34. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
Lionetti M; Fabris S; Cutrona G; Agnelli L; Ciardullo C; Matis S; Ciceri G; Colombo M; Maura F; Mosca L; Gentile M; Recchia AG; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Rossi D; Gaidano G; Morabito F; Ferrarini M; Neri A
Br J Haematol; 2014 Jun; 165(5):629-39. PubMed ID: 24579978
[TBL] [Abstract][Full Text] [Related]
35. MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia.
Wu B; Słabicki M; Sellner L; Dietrich S; Liu X; Jethwa A; Hüllein J; Walther T; Wagner L; Huang Z; Zapatka M; Zenz T
Br J Haematol; 2017 Nov; 179(3):421-429. PubMed ID: 28771672
[TBL] [Abstract][Full Text] [Related]
36. Notch signaling promotes disease initiation and progression in murine chronic lymphocytic leukemia.
Tardivon D; Antoszewski M; Zangger N; Nkosi M; Sordet-Dessimoz J; Hendriks R; Koch U; Radtke F
Blood; 2021 Jun; 137(22):3079-3092. PubMed ID: 33512383
[TBL] [Abstract][Full Text] [Related]
37. NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.
Pozzo F; Bittolo T; Arruga F; Bulian P; Macor P; Tissino E; Gizdic B; Rossi FM; Bomben R; Zucchetto A; Benedetti D; Degan M; D'Arena G; Chiarenza A; Zaja F; Pozzato G; Rossi D; Gaidano G; Del Poeta G; Deaglio S; Gattei V; Dal Bo M
Leukemia; 2016 Jan; 30(1):182-9. PubMed ID: 26165233
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the 3'UTR region of the NOTCH1 gene in chronic lymphocytic leukemia patients.
Abramenko IV; Bilous NI; Chumak AA; Dyagil IS; Martina ZV
Exp Oncol; 2018 Oct; 40(3):211-217. PubMed ID: 30284999
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.
Agnusdei V; Minuzzo S; Frasson C; Grassi A; Axelrod F; Satyal S; Gurney A; Hoey T; Seganfreddo E; Basso G; Valtorta S; Moresco RM; Amadori A; Indraccolo S
Leukemia; 2014 Feb; 28(2):278-88. PubMed ID: 23774673
[TBL] [Abstract][Full Text] [Related]
40. Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation.
De Falco F; Sabatini R; Falzetti F; Di Ianni M; Sportoletti P; Baldoni S; Del Papa B; Screpanti I; Marconi P; Rosati E
Leukemia; 2015 Apr; 29(4):994-8. PubMed ID: 25425197
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
